Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Colonic immune stimulation by targeted oral vaccine.

Kathania M, Zadeh M, Lightfoot YL, Roman RM, Sahay B, Abbott JR, Mohamadzadeh M.

PLoS One. 2013;8(1):e55143. doi: 10.1371/journal.pone.0055143. Epub 2013 Jan 30.

2.

Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.

Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, Cohran V, Klaenhammer TR.

Future Microbiol. 2010 Aug;5(8):1289-96. doi: 10.2217/fmb.10.78.

PMID:
20722604
3.

Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge.

Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4331-6. doi: 10.1073/pnas.0900029106. Epub 2009 Feb 25.

4.

Assessment of Lactobacillus gasseri as a candidate oral vaccine vector.

Stoeker L, Nordone S, Gunderson S, Zhang L, Kajikawa A, LaVoy A, Miller M, Klaenhammer TR, Dean GA.

Clin Vaccine Immunol. 2011 Nov;18(11):1834-44. doi: 10.1128/CVI.05277-11. Epub 2011 Sep 7.

5.

Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.

Park YS, Lee JH, Hung CF, Wu TC, Kim TW.

Infect Immun. 2008 May;76(5):1952-9. doi: 10.1128/IAI.01722-07. Epub 2008 Feb 19.

6.

Up-regulation of MDP and tuftsin gene expression in Th1 and Th17 cells as an adjuvant for an oral Lactobacillus casei vaccine against anti-transmissible gastroenteritis virus.

Jiang X, Yu M, Qiao X, Liu M, Tang L, Jiang Y, Cui W, Li Y.

Appl Microbiol Biotechnol. 2014 Oct;98(19):8301-12. doi: 10.1007/s00253-014-5893-2. Epub 2014 Jul 4.

PMID:
24993357
7.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

8.

Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.

Wen LJ, Hou XL, Wang GH, Yu LY, Wei XM, Liu JK, Liu Q, Wei CH.

Vaccine. 2012 May 9;30(22):3339-49. doi: 10.1016/j.vaccine.2011.08.036. Epub 2011 Aug 19.

PMID:
21856357
9.

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.

Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.

J Immunol. 2003 Jun 1;170(11):5636-43.

10.

Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.

Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK.

Vaccine. 2008 Jan 30;26(5):614-22. doi: 10.1016/j.vaccine.2007.11.072. Epub 2007 Dec 18.

PMID:
18166249
11.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
12.

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Welkos S, Little S, Friedlander A, Fritz D, Fellows P.

Microbiology. 2001 Jun;147(Pt 6):1677-85.

PMID:
11390699
14.

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

Zegers ND, Kluter E, van Der Stap H, van Dura E, van Dalen P, Shaw M, Baillie L.

J Appl Microbiol. 1999 Aug;87(2):309-14.

15.

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens.

Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, Leppla SH, Fujihashi K, Kiyono H, McGhee JR, Boyaka PN.

J Immunol. 2006 Feb 1;176(3):1776-83.

17.

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ.

J Exp Med. 1996 Jan 1;183(1):87-97.

18.

Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.

Hokey DA, Larregina AT, Erdos G, Watkins SC, Falo LD Jr.

Cancer Res. 2005 Nov 1;65(21):10059-67.

19.

A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.

Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.

Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.

PMID:
21504775
20.

Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response.

De Costa AM, Justis DN, Schuyler CA, Young MR.

Int Immunopharmacol. 2012 Jul;13(3):322-30. doi: 10.1016/j.intimp.2012.05.004. Epub 2012 May 16.

Supplemental Content

Support Center